AstraZeneca PLC is 225.4x more valuable than MARAVAI LIFESCIENCES HOLDINGS, INC. by market capitalization ($286.27 B vs $1.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MRVI | AZN |
|---|---|---|
| Market cap | $1.27 B | $286.27 B |
| US-listed rank | #2455 | #45 |
| Revenue (latest FY) | $185.74M | - |
| Net income (latest FY) | -$130.80M | - |
| Net margin | -70.4% | - |
| SEC filings | 393 | 1,004 |
AstraZeneca PLC is 225.4x more valuable than MARAVAI LIFESCIENCES HOLDINGS, INC. by market capitalization ($286.27 B vs $1.27 B).
Full pages: MARAVAI LIFESCIENCES HOLDINGS, INC. and AstraZeneca PLC, or browse the full rankings.